These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17985543)

  • 1. The allogenic nerve graft.
    Berger A; Hierner R; Walter GF
    Acta Neurochir Suppl; 2007; 100():39-41. PubMed ID: 17985543
    [No Abstract]   [Full Text] [Related]  

  • 2. Freeze dried irradiated nerve homograft: a preliminary report.
    Hiles RW
    Hand; 1972 Feb; 4(1):79-84. PubMed ID: 5061383
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurotransplantation of the fetal tissue and compensatory-restorative processes in the recipient nervous system].
    Loseva EV
    Usp Fiziol Nauk; 2001; 32(1):19-37. PubMed ID: 11234432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The xenogeneic transplantation of embryonic nerve tissue (the morphological and immunological aspects)].
    Gilerovich EG
    Morfologiia; 1993; 104(3-4):11-26. PubMed ID: 7889152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ionizing radiation in transplantation.
    van Bekkum DW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):59-65. PubMed ID: 4155159
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurotisation of homologous lyophilized nerve transplants].
    Meier C; Sollmann H
    Res Exp Med (Berl); 1972; 157(3):237-40. PubMed ID: 5046310
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation and treatment of traumatic nerve lesions].
    Jacoby W
    Klin Wochenschr; 1972 Aug; 50(16):757-67. PubMed ID: 5070367
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraventricular brain allografts and xenografts: studies of survival and rejection with and without systemic sensitization.
    Freed WJ; Dymecki J; Poltorak M; Rodgers CR
    Prog Brain Res; 1988; 78():233-41. PubMed ID: 3073411
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological problems in organ transplantation (with reference to oncology)].
    Gazzera G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(9):599-614. PubMed ID: 4932115
    [No Abstract]   [Full Text] [Related]  

  • 10. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents.
    Mason DW; Charlton HM; Jones AJ; Lavy CB; Puklavec M; Simmonds SJ
    Neuroscience; 1986 Nov; 19(3):685-94. PubMed ID: 3796814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of tissue transplant technique to experimental nerve grafting.
    Lewis HP; McLaurin RL
    J Trauma; 1969 Mar; 9(3):227-35. PubMed ID: 5766838
    [No Abstract]   [Full Text] [Related]  

  • 12. The fate of cryopreserved nerve isografts and allografts in normal and immunosuppressed rats.
    Zalewski AA; Fahy GM; Azzam NA; Azzam RN
    J Comp Neurol; 1993 May; 331(1):134-47. PubMed ID: 8320346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attempts at induction of organ regeneration in mammals. I. Results of amputation and nerve tissue graft in rabbit embryos].
    Taban C
    Rev Suisse Zool; 1971 Dec; 78(4):1252-69. PubMed ID: 5145544
    [No Abstract]   [Full Text] [Related]  

  • 14. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation.
    Weissenbacher A; Boesmueller C; Brandacher G; Oellinger R; Pratschke J; Schneeberger S
    Immunotherapy; 2010 Nov; 2(6):783-90. PubMed ID: 21091110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
    Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA
    Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rejection of neural xenotransplants: a role for antibodies.
    Barker RA; Dunnett SB; Richards A
    Transplantation; 1999 Oct; 68(8):1091-2. PubMed ID: 10551631
    [No Abstract]   [Full Text] [Related]  

  • 17. [The morphological validation for the clinical use of a nerve transplantation method].
    Otellin VA
    Zh Vopr Neirokhir Im N N Burdenko; 1999; (4):32-6; discussion 36-7. PubMed ID: 10696681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loss of regenerated host axons in nerve allografts after stopping immunosuppression with cyclosporin A is related to immune effects on allogeneic Schwann cells.
    Zalewski AA; Azzam NA; Azzam RN
    Exp Neurol; 1995 Jun; 133(2):189-97. PubMed ID: 7649224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transplantation of fetal and xenogeneic tissue in Parkinson disease].
    Savel'ev SV; Lebedev VV; Voĭtyna SV; Korochkin LI; Molnar EM; Sukhikh GT
    Biull Eksp Biol Med; 1994 Apr; 117(4):369-72. PubMed ID: 9296663
    [No Abstract]   [Full Text] [Related]  

  • 20. The antigenicity of preserved allografts.
    Friedlaender GE
    Transplant Proc; 1976 Jun; 8(2 Suppl 1):195-200. PubMed ID: 781940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.